Asthma Medications to Know

Asthma drugs are best understood as two jobs: quick-relief (rescue) inhalers and long-term maintenance therapy. Sorting them by that role, rather than alphabetically, mirrors how they're actually used and tested.

Study tip

Split the group in two: rescue bronchodilators (albuterol) for fast relief, and maintenance therapy (inhaled corticosteroids such as fluticasone, plus montelukast). Studying rescue vs. maintenance as separate buckets sticks better than one long list.

Asthma drug list (12)

By generic name, ordered by how commonly each is dispensed.

#Generic nameCommonly used for
7AlbuterolAsthma
15MontelukastAsthma
21Fluticasone PropionateAsthma Maintenance
62Budesonide-FormoterolAsthma
63Fluticasone-SalmeterolAsthma
342BudesonideAsthma Maintenance
343Mometasone FuroateAsthma Maintenance
344BeclomethasoneAsthma Maintenance
345Fluticasone FuroateAsthma Maintenance
346Mometasone / FormoterolAsthma
347Fluticasone / VilanterolAsthma
348Fluticasone / SalmeterolAsthma

Study asthma drugs for free

Turn this list into spaced-repetition flashcards. Create a free account and your progress saves automatically.

Frequently asked questions

What is the difference between a rescue and maintenance inhaler?
Rescue inhalers (like albuterol) act fast for acute symptoms, while maintenance therapy (such as inhaled fluticasone) is taken regularly to prevent symptoms. Sorting asthma drugs into these two buckets is the standard study approach.
Which asthma drug should I learn first?
Albuterol, the most common rescue bronchodilator, is the highest-yield drug in this group to learn first.

More drug categories

Educational study aid — not medical advice. Learn My Drugs is a memorization tool for pharmacy students, technicians, and exam prep. Drug names and uses on this page are simplified for studying and are not a substitute for professional judgment. For clinical, dosing, or safety information, consult the official label and a licensed professional.

Authoritative references: DailyMed, MedlinePlus, and the U.S. FDA.

Last reviewed: May 30, 2026.